This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 119/1/28    most recent CIRCULATIONAHA.108.811992v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sugamura, K. Articles by Ogawa, H. Search for Related Content PubMed PubMed Citation Articles by Sugamura, K. Articles by Ogawa, H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Coronary Artery Disease Related Collections Obesity Pathophysiology Risk Factors Mechanism of atherosclerosis/growth factors Related Article

(Circulation. 2009;119:28-36.)
© 2009 American Heart Association, Inc.

Coronary Heart Disease

Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages

Koichi Sugamura, MD; Seigo Sugiyama, MD, PhD; Toshimitsu Nozaki, MD; Yasushi Matsuzawa, MD; Yasuhiro Izumiya, MD, PhD; Keishi Miyata, MD, PhD; Masafumi Nakayama, MD, PhD; Koichi Kaikita, MD, PhD; Toru Obata, PhD; Motohiro Takeya, MD, PhD; Hisao Ogawa, MD, PhD

From the Departments of Cardiovascular Medicine (K.S., S.S., T.N., Y.M., Y.I., M.N., K.K., H.O.), Molecular Genetics (K.M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; and Department of Molecular Cell Biology (T.O.), Institute of DNA Medicine, Jikei University School of Medicine, Tokyo, Japan.

Correspondence to Seigo Sugiyama, MD, PhD, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1–1–1 Honjo, Kumamoto City 860–8556, Japan. E-mail ssugiyam{at}gpo.kumamoto-u.ac.jp

Received August 1, 2008; accepted October 14, 2008.

Background— Cannabinoid 1 (CB1) receptor blockade with rimonabant represents a clinical therapeutic strategy for obesity. Recently, the role of the endocannabinoid system has been described in peripheral organs. We sought to determine whether the endocannabinoid system could be involved in human atherosclerosis and whether CB1 receptor blockade could modulate proinflammatory activity in macrophages.

Methods and Results— mRNA expression levels of CB1 receptor in coronary atherectomy samples were significantly higher in patients with unstable angina than in those with stable angina (3.62±2.96-fold; n=7; P<0.05). Immunoreactive area analysis of the coronary artery showed that CB1 receptor expression was greater in lipid-rich atheromatous plaques than in fibrous plaques, especially in CD68 macrophages (9.5±1.2% versus 0.6±0.6%; n=5; P<0.01). Levels of blood endocannabinoids were significantly higher in patients with coronary artery disease (n=20) than those without coronary artery disease (n=20) (median [interquartile range]: anandamide, 1.048 pmol/mL [0.687 to 1.387 pmol/mL] versus 0.537 pmol/mL [0.468 to 0.857 pmol/mL], P<0.01; 2-arachidonoyl glycerol, 13.30 pmol/mL [6.65 to 16.21 pmol/mL] versus 7.67 pmol/mL [6.39 to 10.03 pmol/mL], P<0.05). In cultured macrophages, expression of CB1 receptor was significantly increased during monocyte-macrophage differentiation (1.78±0.13-fold; n=6; P<0.01). CB1 receptor blockade in macrophages induced a significant increase in cytosolic cAMP (29.9±13.0%; n=4; P<0.01), inhibited phosphorylation of c-Jun N-terminal kinase (–19.1±12.6%, n=4; P<0.05), and resulted in a significant decrease in the production of proinflammatory mediators (interleukin-1β, –28.9±10.9%; interleukin-6, –24.8±7.6%; interleukin-8, –22.7±5.2%; tumor necrosis factor-, –13.6±4.8%; matrix metalloproteinase-9, –16.4±3.8%; n=4 to 8; P<0.01).

Conclusions— Patients with coronary artery disease demonstrated the activation of the endocannabinoid system with elevated levels of blood endocannabinoids and increased expression of CB1 receptor in coronary atheroma. CB1 receptor blockade exhibited antiinflammatory effects on macrophages, which might provide beneficial effects on atherogenesis.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2009 119: 1-4. [Extract] [Full Text]